Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study. (29th October 2017)

• Record Type: Journal Article
• Authors: Maremmani, C.; Cavallo, F.; Purcaro, C.; Rossi, G.; Salvadori, S.; Rovini, E.; Esposito, D.; Pieroni, A.; Ramat, S.; Vanni, P.; Fattori, B.; Meco, G.
• Is Part Of: Acta neurologica Scandinavica. Volume 137:Number 2(2018)
• Page Start: 204
• Page End: 211
• Publication Date: 2017-10-29
• Subjects: Italian Olfactory Identification Test -- Parkinson's disease -- Parkinson's disease preclinical diagnosis -- preclinical Parkinson's disease -- smell identification test -- wearable sensors; Neurology -- Periodicals; 616.8
• DOI: 10.1111/ane.12862
• Languages: English
• ISSNs: 0001-6314

Abstract

Abstract : Objectives: Preclinical diagnosis of Parkinson's disease (PD) is nowadays a topic of interest as the neuropathological process could begin years before the appearance of motor symptoms. Several symptoms, among them hyposmia, could precede motor features in PD. In the preclinical phase of PD, a subclinical reduction in motor skills is highly likely. In this pilot study, we investigate a step‐by‐step method to achieve preclinical PD diagnosis. Material and methods: We used the IOIT (Italian Olfactory Identification Test) to screen a population of healthy subjects. We identified 20 subjects with idiopathic hyposmia. Hyposmic subjects underwent an evaluation of motor skills, at baseline and after 1 year, using motion analysis sensors previously created by us. Results: One subject showed significant worsening in motor measurements. In this subject, we further conducted a dopaminergic challenge test monitored with the same sensors and, finally, he underwent [ 123 I]‐FP/CIT (DaTscan) SPECT brain imaging. The results show that he is probably affected by preclinical PD. Conclusions: Our pilot study suggests that the combined use of an olfactory test and motor sensors for motion analysis could be useful for a screening of healthy subjects to identify those at a high risk of developing PD.